Intra-Cellular Therapies
ITCI
#1743
Rank
NZ$16.20 B
Marketcap
$152.85
Share price
0.86%
Change (1 day)
68.31%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$4.39 M-89.58%
2023NZ$42.15 M51.56%
2022NZ$27.81 M16.21%
2021NZ$23.93 M25.98%
2020NZ$18.99 M-33.46%
2019NZ$28.54 M2213.17%
2018NZ$1.23 M-95.97%
2017NZ$30.59 M29.42%
2016NZ$23.63 M-65.91%
2015NZ$69.33 M104.09%
2014NZ$33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0.01 MNZ$0.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 MNZ$1.28 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0 MNZ$2.24 M๐Ÿ‡บ๐Ÿ‡ธ USA